Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)
National Institutes of Health
- Funding range
- $0 – $7M
- Application window
- Opens: Not listed
- Closes: June 20, 2029
- Applications Status:Upcoming
- Location
- National
Source & verification
- Original funding source
- www.grants.gov
- Last checked
- October 28, 2026
- Last reviewed by Ryplle
- Not yet recorded
Source checks may be automated. Review dates reflect a recorded staff review. Confirm current requirements with the funder.
Eligibility at a glance
- Listed applicant types
- Nonprofit, Student, Business
- Geographic eligibility
- National
- Matching funds
- Not specified — check with the funder
- Major exclusions
- Not specified — check with the funder
Listed types are not a determination of eligibility. The funder’s full requirements take precedence.
Full eligibility requirements
Eligible applicants: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; For profit organizations other than small businesses; City or township governments; Native American tribal governments (Federally recognized); Private institutions of higher education; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; County governments; Native American tribal organizations (other than Federally recognized tribal governments); Independent school districts; Public and State controlled institutions of higher education; Public housing authorities/Indian housing authorities; Small businesses; Special district governments; State governments; Others (see text field entitled "Additional Information on Eligibility" for clarification).
About this grant
The purpose of this notice of funding opportunity (NOFO) is to support implementation research on strategies to improve the uptake, implementation, sustainment, scale and/or spread of evidence-based prevention, treatment, and care interventions in communities in the U.S. significantly impacted by HIV. Projects should be large in scale with high potential for research and public health impact. Specifically, large single site studies, multi-site studies, and comparative studies are encouraged as scientifically appropriate.
Contact information
- National Institutes of Health
- OD-OARHIVISRFA27-018@nih.gov
- 301-402-2541

